A new review highlights how glutamine metabolism shapes the complex tumor microenvironment, offering fresh perspectives on how metabolic interactions influence cancer progression and therapeutic response. This study emphasizes that glutamine isn’t merely an energy source but a regulator of cellular behavior within the tumor ecosystem, linking survival, adaptation, and immune responses. Key findings reveal that tumor cells and stromal components communicate through metabolic exchanges, with macrophages, T cells, fibroblasts, and dendritic cells playing pivotal roles. In some contexts, glutamine enhances anti-tumor defenses, while in others, it suppresses immune activity, fostering immunosuppression and tumor survival. The review underscores the importance of targeting these metabolic pathways to develop more effective therapies. Personal insights suggest that understanding glutamine’s role in tumor-stroma interactions could lead to novel strategies that address both tumor growth and immune evasion. While the focus remains on current research, broader trends indicate a shift toward therapies that consider the entire biological context rather than solely focusing on cancer cells.
